Statistics
Publications
36
Citations
2.1K
H-Index
24
Active since
1989
Ming‐Hong Hao is an author at Boehringer Ingelheim (United States) specializing in drug discovery, pharmacology, and medicinal chemistry.
Publications per year
1989–2022
36
36
H3B-6527 Is a Potent and Selective Inhibitor of FGFR4 in FGF19-Driven Hepatocellular Carcinoma
Jaya Julie Joshi, Heather Coffey, Erik Corcoran et al. · Cancer Research · 2017 · 151 citations
Medicine, Oncology, Pharmacology +15
Evasion of immunosurveillance by genomic alterations of PPARγ/RXRα in bladder cancer
Manav Korpal, Xiaoling Puyang, Zhenhua J. Wu et al. · Nature Communications · 2017 · 145 citations · Full text
Medicine, Immunology, Oncology +17
1–5 of 36